Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Tilray Brands Inc TLRY

Alternate Symbol(s):  T.TLRY

Healthcare Cannabis Cannabis
Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol... see more

NDAQ:TLRY - Post Discussion

Tilray Brands Inc > Target raised to $3.00
View:
Post by therivercard on Jan 13, 2025 9:52pm

Target raised to $3.00

Simon is a tireless communicator for Tlry, fy '25 guidance revenue $950m-$1B, most well positioned and diversified globally in this sector.   With some anticipated relaxation of the excise tax and the logical US legalization of medical marijuana (Trump will exercise the tax grab) adding to my position today on market weakness was a no brainer.  GLTALs

Tilray (NASDAQ:TLRY) Price Target Raised to $3.00 at Canaccord Genuity Group. Tilray (NASDAQ:TLRY - Get Free Report) had its target price lifted by research analysts at Canaccord Genuity Group from $2.00 to $3.00 in a report released on Monday,BayStreet.CA reports. The firm presently has a "buy" rating on the stock.

Comment by WolfOakville on Jan 14, 2025 5:55am
Cannacord. LOL.
Tilray Brands Inc